![]() He received first dose AZD1222 vaccine on March 20, 2021, during the Iran national vaccination program. In this study, we are going to report a herpes‐like skin lesion following AZD1222 vaccination.Ī 28‐year‐old man, with no systemic disease, presented with herpes‐like skin lesions on his right upper eyelid. 3 To our knowledge, herpes‐like skin lesions have not been reported in the azd1222 vaccine clinical trials, 4 but some spontaneous reports in this regard from the UK have been received between April 1 and July 21, 2021. Herpes virus reactivation has been reported following trivalent influenza, hepatitis A, and rabies vaccines, suggesting vaccine‐modulated immunomodulation. ![]() Furer et al, have reported six cases of herpes zoster following BNT162b2 mRNA COVID‐19 vaccination. 1 Viral infections after COVID‐19 vaccination have been reported. Chadox1 ncov‐19 (AZD1222) is one of them, which has been used in the national vaccination programs against the disease in many countries. Up to now, more than 50 vaccines against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) have been developed and presented in clinical trials. Since coronavirus disease 2019 (COVID‐19), pandemic, safe, and effective vaccination against it became vital. This study reports a case of herpes‐like skin lesions after chadox1 ncov‐19 (azd1222) vaccine in a 28‐year‐old man and reveals a possible relation between this vaccine and viral reactivation. ![]() Since then, viral infections after vaccination have been reported. Vaccination against coronavirus disease 2019 (COVID‐19) has been launched by many countries.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |